Dr Kyle R Dyer
BA(Hons), PGDip Psych Prac, PhD
Project Manager
Contact details:
Email: kyle.dyer@kcl.ac.uk
Biography:
Dr Dyer migrated from Australia to the United Kingdom in June 2008. He is a psycho-pharmacologist who completed his PhD within the Department of Clinical & Experimental Pharmacology and the Department of Psychology at the University of Adelaide in 2000. From 2000-2008, he was a Senior Lecturer within the School of Medicine & Pharmacology at the University of Western Australia where he developed and managed a multidisciplinary research group comprising university and Government employed research staff and administrative assistants. This position involved joint status at the Drug & Alcohol Office (WA Department of Health) where he was responsible for the management of clinical research concerning the treatment of alcohol and other drug dependencies; the provision of workforce education and training; and supporting clinical practice and policy development via the provision of consultancy, Ministerial Briefings and patient treatment plans. From 1996-2000 he was a Lecturer in workforce development at the National Centre for Education & Training on Addiction (School of Medicine, Flinders University of South Australia).
Dr Dyer has been conducting research into the nature and treatment of drug dependence, the efficacy of point-of-collection oral fluid drug tests, the relationship between drug concentration and psycho-behavioural and cognitive impairment, medical education and workforce development. Parallel research areas include the diagnosis and management of mental health problems and neuro-cognitive impairment among drug dependent individuals; the assessment and management of illicit drug withdrawal and dependence; and the relationship between acute and chronic drug use and cognitive functioning, including the areas of drugs and driving and drug impairment in the workplace. This research activity has been supported by numerous research grants, and Government and Industry sourced funding. He has published his work in high impact medical, psychological and pharmacological journals, and promoted his work at numerous conferences and through the media.
He has extensive experience in undergraduate and postgraduate education delivered through various modalities (e.g. didactic, small group, distance education), workforce development, curricula design and the development and marketing of postgraduate clinical degrees. He has been a guest lecturer at numerous universities in Australia and England, and is currently a Visiting Fellow in the School of Psychology, London South Bank University and External Examiner at the Institute of Psychiatry, Kings College London. He has received an Excellence in Teaching Award from the University of Western Australia and a National Australian Drug & Alcohol Award: Excellence in Treatment for establishing the East Perth Neuropsychology Clinic.
Publications:
Moss, AC., Dyer, KR. (2010) Psychology of Addictive Behaviours. London: Palgrave Macmillan
Stritzke, W., McEvoy, P., Wheat, L., Dyer, K., French, D. (2007) The yin and yang of indulgence and restraint: The ambivalence model of craving. In O’Neal. P. (Ed) Psychology of Motivation. Hauppauge, NY: Nova Science Publishers p 31-47
Dyer, K.R., Ali, R., White, J.M., Cormack, S., Gaughwin, M. (1992) Correlates of Risky Needle Use Amongst Methadone Clients in South Australia. In White, J.(Ed.) Drug Problems in Society: Dimensions and Perspectives. Nepean Publishing :Melbourne, pp 402-7.
PEER-REVIEWED PUBLICATIONS
Moss, AC., Dyer, K., Albery, I., Allsop, S., Kypriou, K. Erskine, J. (2010) Alcohol pharmacokinetics, decision making and folk wisdom: A Reply to Moxnes and Jensen (2009) Drug & Alcohol Dependence, 109, 1-3.
Moss, AC., Dyer, KR., Albery, I. (2009) Knowledge of drinking guidelines does not guarantee sensible drinking: Evidence from London medical students. The Lancet, 374, 1242.
Schubert, S., Hansen, S., Dyer, K., Rapley, M. (2009) ‘ADHD sufferer’ or ‘illicit drug user’? The management of medico-moral membership categories by users of drug dependence services. Discourse & Society 20(4) 499-516.
Cruickshank, C., Dyer, KR. (2009) A review of the clinical pharmacology of methamphetamine. Addiction, 104, 1085-1099.
Cruickshank, C., Montebello, M., Dyer, K.R., Quigley, A., Blaszczyk, J., Tomkins, S., Shand, D. (2008) A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. Drug & Alcohol Review, 27(3), 326-333.
Dyer, KR., Wilkinson, C. (2008) The detection of illicit drugs in oral fluid: A potential strategy to reduce illicit drug-related harm. Drug & Alcohol Review, 27(1), 99-107.
Wilkinson, C., Dyer, K.R., Mitchell, T., Ilett, K and Wolff, K (2007) A novel matrix for therapeutic drug monitoring in methadone maintenance patients: are oral fluid methadone levels useful? Therapeutic Drug Monitoring 29(4) p 481-2
Wilkinson, C., Dyer, K.R., Ilett, K and O’Halloran, S (2007) Oral fluid as a matrix for detecting illicit drug use: The validity of bench-top immunoassay screening. Therapeutic Drug Monitoring 29(4) p 499
Mitchell,T.B., Dyer, K.R., Newcombe, D., Somogyi, A., White, J. (2006) Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients. Addiction Biology, 11, 170-174
Mitchell, T.B., Dyer, K.R., Peay, E.R. (2006) Patient and physician characteristics in relation to clinical decision making in methadone maintenance treatment. Substance Use and Misuse, 41(3), 393-404
Dyer, K.R., Cruickshank, C (2005) Depression and other psychological health problems among methamphetamine dependent patients in treatment: implications for assessment and treatment outcome. Australian Psychologist 40(2),96-108.
Dyer, K.R. (2005) Methadone Maintenance treatment and mood disturbances: pharmacological and psychological implications. Heroin Addiction and Related Clinical Problems, 7(2), 5-11.
O’Halloran, S., Lam, V., Dyer, K.R, Taylor, H., Ilett, K.F.(2005) Development of a GC-MS method for confirmation of methamphetamine in oral fluid and it’s use in assessment of the performance of an on-site saliva immunoassay testing system Therapeutic Drug Monitoring. 27(2):225, April 2005.
Rickwood, R., Dyer, K., Melrose, J., Mentha, H., Ryder, D. (2005) Perspectives in psychology: Substance Use. Australian Psychological Society : Fitzroy, Vic.
Cole, A., Morton, E., Collins, M., Dyer, KR., Newcombe, K. (2005) Validation of a brief screening battery to assess neuropsychological impairment in drug and alcohol dependent patients. Australian Journal of Psychology, 57, 9-9.
Morton, E., Cole, A., Fox, A., Collins, M., Dyer, KR., Newcome, K. (2005) The neurocognitive effects of methamphetamine dependence. Australian Journal of Psychology, 57, 13-13.
Mitchell, T.B., Dyer, K.R., Newcombe, D., Salter, A., Somogyi, A., Bochner, F., White, J.M. (2004) Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- versus (R)- methadone exposure. British Journal of Clinical Pharmacology 58(6), 609-617
Stritzke WGK, Wheat L, McEvoy PM, Dyer KR, French DJ (2004) Examining craving as an entity and process in clinical samples. Alcoholism-clinical and experimental research 28 (5): 146a
Miller-Lewis, L., Wade, T., Dyer, K.R. (2003) The prevalence of cannabis use in an Australian tertiary student population. Australian Psychologist, 38(1), 73-77.
Rickwood, R., Dyer, K., Melrose, J., Mentha, H., Ryder, D. (2003) Psychology and substance use: Potential contributions and professional training needs. Australian Psychological Society Position Paper: Fitzroy, Vic.
Dyer, K.R., White, J.M., Foster, D., Bochner, F., Menelaou, A. (2001) The relationship between mood state and plasma methadone concentration in maintenance patients. Journal of Clinical Psychopharmacology, 21 (1), 78-84.
Foster, D., Dyer, K.R., Somogyi, A., White, J., Bochner, F. (2000) Steady-state pharmacokinetics of (R)- and (S)- methadone in methadone maintenance patients. British Journal of Clinical Pharmacology, 50(5), 427-440
White, J.M., Dyer, K.R., Foster, D., Newcombe, D., Menelaou, A., Bochner, F., Somogyi, A. (2000) Determinants and management of withdrawal in methadone maintenance patients. Heroin Addiction and Related Clinical Problems, 2, 58.
Dyer, K.R., Foster, D., White, J.M., Somogyi, A., Menelaou, A., Bochner, F. (1999) Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: Comparison of those who do and do not experience withdrawal and concentration effect relationships. Clinical Pharmacology and Therapeutics, 65(6), 685-694.
Dyer, K.R. (1998) Withdrawal severity during the inter-dosing interval among methadone clients: Methadone pharmacokinetics and pharmacodynamics. In Dyer, K., Addy, D. (Eds.)(1998) New Perspectives: Proceedings of the 1997 NCETA Research Seminar Program. Adelaide: National Centre for Education & Training on Addiction. p25-41.
Foster, D., Somogyi, A., Dyer, K.R., White, J., Bochner, F. (1998) Pharmacokinetics of (R)- and (S)- methadone in a methadone maintenance population. Naunyn-Schiedebergs Archives of Pharmacology, 358 (1), P4721 Suppl.2
Bochner, F., Dyer, K.R., Foster, D., White, J., Somogyi, A., Menelaou, A. (1997) Withdrawal severity in methadone maintenance patients is likely to have a pharmacokinetic rather than a pharmacodynamic cause. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists,Vol. 4, p125.
Foster, D., Somogyi, A., Bochner, F., White, J., Dyer, K.R. (1997) Validation and application of an assay for the quantification of (R )- and (S)- methadone in human plasma. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Vol. 4, p120.
Foster, D., Menelaou, A., Dyer, K.R., White, J.M., Somgyi. A., Bochner, F. (1997) Pharmacokinetics of racemic methadone in a methadone maintenance population. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Vol. 4, p150.
Dyer, K.R., White, J.M., Bochner, F., Menelaou, A., Somogyi, A. (1996) Mood state and plasma concentrations in methadone maintenance. In L. Harris (Ed) Problems of Drug Dependence. Rockville:NIDA Research Monograph 174, p301.
Dyer, K.R. (1996) Methadone maintenance clients who consistently report withdrawal symptoms. In Topp, L., Dillon, P. (Eds.) Looking to the future: A Second Generation of Drug Research. Sydney: NDARC Monograph No 29, pp 155-166.
Menelaou, A., Dyer, K.R., White, J.M., Somogyi, A., Foster, D., Bochner, F. (1995) Methadone disposition and plasma concentration-effect relationships in a methadone maintenance program. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Vol. 2, p112.
Dyer, K.R., White, J.M. (1997) Patterns of symptom complaints in methadone maintenance patients. Addiction, 92(11), 1445-1455.
White, J., Dyer, KR, Bochner, F., Menelaou, A., Somogyi, A. (1996) Determinants of withdrawal in a methadone maintenance population. European Neuropsychopharmacology, 6(3), 66-68
White, J.M., Dyer, K.R., Ali, R.L., Gaughwin, M., Cormack, S. (1994) Injecting behaviour and risky needle use amongst methadone maintenance clients. Drug and Alcohol Dependence, 34, 113-119.